Linhai Li

广州医科大学

H指数:26

被引数:2,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A novel hydroquinone-based chemiluminescent biosensing platform for ultrasensitive sensing of α-glucosidase activity

一种基于对苯二酚的新型化学发光生物传感平台，用于超灵敏检测α-葡萄糖苷酶活性

BIOSENSORS & BIOELECTRONICS

IF10.5

2026-07-220

PRE

Chemiluminescence imaging probes for the detection of reactive species and biomolecules in vivo and in vitro

化学发光成像探针在活体和体外中对活性物种和生物分子的检测

Talanta

IF6.1

2025-10-280

PRE

Whole genome study and construction of SHERLOCK detection method for endemic strains of Burkholderia pseudomallei in Hainan based on third-generation sequencing

基于第三代测序的海南省地方性 Burkholderia pseudomallei 菌株的全基因组研究及 SHERLOCK 检测方法的构建

MICROBIOLOGY SPECTRUM

IF3.8

2025-09-010

PRE

Gram-negative intratumoral bacteria mediate lymph node metastasis through LPS-TLR4/MAPK signaling pathway in cervical cancer

革兰氏阴性肿瘤内细菌通过LPS-TLR4/MAPK信号通路介导宫颈癌的淋巴结转移

Journal of Infection

IF11.9

2025-06-110

Transcriptomic landscapes underlying response and resistance to HDAC inhibitor chidamide in triple-negative breast cancer

三阴性乳腺癌对HDAC抑制剂chidamide的应答与耐药的转录组景观

Genes & Diseases

IF9.4

2025-05-080

OAAI

Optimizing two-step and one-step SHERLOCK nucleic acid detection assays and their applications in detecting influenza A and B viruses

MICROCHEMICAL JOURNAL

IF5.1

2025-04-010

PRE

Efficient Separation-Free and Wash-Free Immunoassay for Sensitive Detection of Biomarkers Based on the Distance-Driven Chemiluminescent Technique

基于距离驱动化学发光技术的分离自由、洗涤自由的免疫分析方法，用于生物标志物的敏感检测

ANALYTICAL CHEMISTRY

IF6.7

2025-03-201

PRE

Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2025-03-010

PRE

Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple-Negative Breast Cancer: A Comprehensive Analysis

三阴性乳腺癌中PPAR信号通路的临床相关性和药物调节: 综合分析

PPAR RESEARCH

IF3.1

2024-12-200

Proteomic profiling identifies feedback-activated signaling pathways that may limit chidamide efficacy in triple-negative breast cancer

蛋白质组学分析鉴定出可能限制沙利霉素疗效的反馈激活信号通路，在 triple-negative breast cancer 中。

ASIAN JOURNAL OF SURGERY

IF3.8

2024-12-010

OAAI

The Epstein-Barr virus small capsid protein BFRF3 disrupts the NF-кB signaling pathway by inhibiting p65 activity

爱泼斯坦-巴尔病毒小衣壳蛋白BFRF3通过抑制p65活性破坏NF-к b信号通路

FASEB JOURNAL

IF4.2

2024-09-201

PRE

Integrative Pan-Cancer Analysis Reveals the Oncogenic Role of MND1 and Validation of MND1's Role in Breast Cancer

泛癌综合分析揭示了MND1的致癌作用，并验证了MND1在乳腺癌中的作用

inflammation research

IF4.1

2024-07-010

AI-driven analysis establishes the single base substitution signatures as personalized prognostic predictors for five-year survival of gastric cancer

GENES & DISEASES

IF9.4

2024-07-010

OAAI

Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development

PPAR激活在癌症治疗抵抗中的作用: 联合治疗和药物开发的意义

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-02-015

PRE

KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1

CARCINOGENESIS

IF2.9

2023-10-130

OAAI

Epstein-Barr Virus Envelope Glycoprotein gp110 Inhibits IKKi-Mediated Activation of NF-?B and Promotes the Degradation of β-Catenin

MICROBIOLOGY SPECTRUM

IF3.8

2023-06-155

OAAI

Nanomaterial-based chemiluminescence systems for tracing of reactive oxygen species in biosensors

基于纳米材料的化学发光系统用于示踪生物传感器中的活性氧

TRAC-TRENDS IN ANALYTICAL CHEMISTRY

IF12

2023-05-0119

PRE

Epstein-Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2023-05-016

OAAI

SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-03-1521

OAAI

Predicting thalassemia using deep neural network based on red blood cell indices

CLINICA CHIMICA ACTA

IF2.9

2023-03-016

PRE

Linhai Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向